Sanofi to Invest $17.2 Million in Innate Pharma as Part of Review of 2016 License Agreement
In This Article:
Innate Pharma SA (IPHA) and Sanofi (SNY) have agreed that the latter will invest up to 15 million eu
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.
Terms and Privacy Policy